Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia

被引:66
作者
Hatzistilianou, Maria [1 ]
Rekliti, Aleka [1 ]
Athanassiadou, Fanni [1 ]
Catriu, Dorothea [1 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Paediat 2, Thessaloniki 55132, Greece
关键词
CRP; PCT; Cytokines; IL-1b; IL-8; sTNFRII; ALL; Children; C-REACTIVE PROTEIN; ADENOSINE-DEAMINASE; SERUM; INTERLEUKIN-6; RECEPTOR; CANCER; FEVER;
D O I
10.1007/s00011-009-0100-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of this study was to assess the value of procalcitonin (PCT), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-a), interleukin (IL)-1b, IL-8, and soluble TNF receptor II (sTNFRII) in early and rapid diagnosis of infection in neutropenic children with acute lymphoblastic leukemia (ALL) and to distinguish bacterial from viral infections. The study included five groups (A, B, C, D, and E) of children with ALL undergoing intensive chemotherapy. Groups A and B consisted of neutropenic children with bacterial and viral infection, respectively. Groups C and D consisted of nonneutropenic children with bacterial and viral infection, respectively. Group E consisted of children without neutropenia and without fever. In all groups, blood samples were collected upon admission and then for 7 days on a daily basis. Levels of CRP, PCT, TNF-a, IL-1b, IL-8, and sTNFRII were determined in all blood samples. We found a highly significant difference in PCT levels between bacterial and nonbacterial episodes. Sensitivity and specificity of PCT were 94 and 96.5%, respectively. Serial measurement of PCT levels on a daily basis seems to be helpful for early prediction of severe bacterial infections, monitoring febrile episodes regarding response to antibiotic therapy, and early detection of complications in the infectious process.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 32 条
  • [1] Alexander SW, 1999, CURR CLIN TOPICS INF, V19, P160
  • [2] Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults
    Bernard, L
    Ferrière, F
    Casassus, P
    Malas, F
    Lévêque, S
    Guillevin, L
    Lortholary, O
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) : 914 - 915
  • [3] Chesney J, 1998, J IMMUNOL, V160, P419
  • [4] Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial
    Christ-Crain, M
    Jaccard-Stolz, D
    Bingisser, R
    Gencay, MM
    Huber, PR
    Tamm, M
    Müller, B
    [J]. LANCET, 2004, 363 (9409) : 600 - 607
  • [5] Febrile neutropenia in children
    Crokaert, F
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (02) : 173 - 176
  • [6] Emporiadou M., 2005, EUR J INFLAMM, V3, P75
  • [7] Fever and neutropenia - How to use a new treatment strategy
    Finberg, RW
    Talcott, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) : 362 - 363
  • [8] Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II
    Fleischhack, G
    Kambeck, I
    Cipic, D
    Hasan, C
    Bode, U
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) : 1093 - 1102
  • [9] Procalcitonin, a marker of bacterial infection
    Gendrel, D
    Bohuon, C
    [J]. INFECTION, 1997, 25 (03) : 133 - 134
  • [10] Current approaches for risk stratification of infectious complications in pediatric oncology
    Haertel, Christoph
    Deuster, Maresa
    Lehrnbecher, Thomas
    Schultz, Christian
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (06) : 767 - 773